Papers
53
Total Citations
2,408
H-Index
25
About
Abolfazl Hosseini is a pioneering urologic surgeon and researcher whose work has fundamentally shaped the field of robot-assisted radical cystectomy (RARC) for bladder cancer treatment. Based primarily at Karolinska University Hospital, he has been at the forefront of developing and refining intracorporeal urinary diversion techniques — a technically demanding advancement that keeps the entire surgical reconstruction inside the patient's body during robotic bladder removal. His most celebrated contributions include landmark studies on intracorporeal neobladder construction and comparative outcomes through the International Robotic Cystectomy Consortium, a multi-institutional collaborative effort that has generated some of the most influential evidence in the field. His 2017 consortium outcomes paper (216 citations) and his 2011 pioneering intracorporeal diversion study (211 citations) together represent foundational literature for surgeons worldwide. His research into learning curve effects and enhanced recovery protocols has further translated surgical innovation into practical clinical guidance, evidenced by his influential 2016 EAU consensus paper (141 citations). Beyond bladder cancer, Hosseini has contributed meaningfully to robot-assisted radical prostatectomy outcomes, examining biochemical recurrence and surgical margin significance across large cohorts. Collectively accumulating over 1,400 citations, his body of work reflects both technical mastery and a commitment to evidence-based refinement of minimally invasive urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10